CoChat

Recent advances and application of generative adversarial networks in drug discovery, development, and targeting

Open access
Tripathi, Satvik, Augustin, Alisha Isabelle, Dunlop, Adam, Sukumaran, Rithvik, Dheer, Suhani, Zavalny, Alex, Haslam, Owen, Austin, Thomas, Donchez, Jacob, Tripathi, Pushpendra Kumar, Kim, Edward · 2022 · Artificial Intelligence in the Life Sciences
Cited by 59

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

A rising amount of research demonstrates that artificial intelligence and machine learning approaches can provide an essential basis for the drug design and discovery process. Deep learning algorithms are being developed in response to recent advances in computer technology as part of the creation of therapeutically relevant medications for the treatment of a variety of ailments. In this review, we focus on the most recent advances in the areas of drug design and discovery research employing generative deep learning methodologies such as generative adversarial network (GAN) frameworks. To begin, we examine drug design and discovery studies that use several GAN methodologies to evaluate one key application, such as molecular de novo design in drug design and discovery. Furthermore, we discuss many GAN models for dimension reduction of single-cell data at the preclinical stage of the drug development pipeline. We also show various experiments in de novo peptide and protein creation utilizing GAN frameworks. Furthermore, we discuss the limits of past drug design and discovery research employing GAN models. Finally, we give a discussion on future research prospects and obstacles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ailsci.2022.100045

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 96

  1. Hessler, 2018, Artificial intelligence in drug design, Molecules, 23, 2520, 10.3390/molecules23102520 · DOI · Paper page
  2. Jing, 2018, Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era, AAPS J, 20, 1, 10.1208/s12248-018-0210-0 · DOI · Paper page
  3. Rifaioglu, 2019, Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases, Brief Bioinformatics, 20, 1878, 10.1093/bib/bby061 · DOI · Paper page
  4. Ekins, 2016, The next era: deep learning in pharmaceutical research, Pharm Res, 33, 2594, 10.1007/s11095-016-2029-7 · DOI · Paper page
  5. Kingma D.P., Welling M.. Auto-encoding variational bayes. arXiv preprint arXiv:131261142013;.
  6. Wang, 2018, Vasc: dimension reduction and visualization of single-cell rna-seq data by deep variational autoencoder, Genomics Proteomic Bioinform, 16, 320, 10.1016/j.gpb.2018.08.003 · DOI · Paper page
  7. Ghasemi, 2018, Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks, Drug Discov Today, 23, 1784, 10.1016/j.drudis.2018.06.016 · DOI · Paper page
  8. Ching, 2018, Opportunities and obstacles for deep learning in biology and medicine, J R Soc Interface, 15, 20170387, 10.1098/rsif.2017.0387 · DOI · Paper page
  9. Dana, 2018, Deep learning in drug discovery and medicine; scratching the surface, Molecules, 23, 2384, 10.3390/molecules23092384 · DOI · Paper page
  10. Lin, 2018, A deep learning approach for predicting antidepressant response in major depression using clinical and genetic biomarkers, Front Psychiatry, 9, 290, 10.3389/fpsyt.2018.00290 · DOI · Paper page
  11. Goodfellow, 2014, Generative adversarial nets, Adv Neural Inf Process Syst, 27
  12. Zhao, 2018, Synthesizing retinal and neuronal images with generative adversarial nets, Med Image Anal, 49, 14, 10.1016/j.media.2018.07.001 · DOI · Paper page
  13. Hu, 2018, Unsupervised learning for cell-level visual representation in histopathology images with generative adversarial networks, IEEE J Biomed Health Inform, 23, 1316, 10.1109/JBHI.2018.2852639 · DOI · Paper page
  14. Mardani, 2018, Deep generative adversarial neural networks for compressive sensing MRI, IEEE Trans Med Imaging, 38, 167, 10.1109/TMI.2018.2858752 · DOI · Paper page
  15. Lin, 2020, A deep adversarial variational autoencoder model for dimensionality reduction in single-cell RNA sequencing analysis, BMC Bioinformatics, 21, 1, 10.1186/s12859-020-3401-5 · DOI
  16. Alqahtani, 2021, Applications of generative adversarial networks (GANs): an updated review, Arch Comput Methods Eng, 28, 525, 10.1007/s11831-019-09388-y · DOI · Paper page
  17. Mirza M., Osindero S.. Conditional generative adversarial nets. arXiv preprint arXiv:141117842014a;.
  18. Makhzani A., Shlens J., Jaitly N., Goodfellow I., Frey B.. Adversarial autoencoders. arXiv preprint arXiv:1511056442015;.
  19. Guimaraes G.L., Sanchez-Lengeling B., Outeiral C., Farias P.L.C., Aspuru-Guzik A.. Objective-reinforced generative adversarial networks (ORGAN) for sequence generation models. arXiv preprint arXiv:170510843
  20. Sanchez-Lengeling B., Outeiral C., Guimaraes G.L., Aspuru-Guzik A.. Optimizing distributions over molecular space. an objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC)2017a;. · DOI · Paper page
  21. Putin, 2018, Reinforced adversarial neural computer for de novo molecular design, J Chem Inf Model, 58, 1194, 10.1021/acs.jcim.7b00690 · DOI · Paper page
  22. Putin, 2018, Adversarial threshold neural computer for molecular de novo design, Mol Pharm, 15, 4386, 10.1021/acs.molpharmaceut.7b01137 · DOI · Paper page
  23. Prykhodko, 2019, A de novo molecular generation method using latent vector based generative adversarial network, J Cheminform, 11, 1, 10.1186/s13321-019-0397-9 · DOI · Paper page
  24. Aha D.W. Kibler D. Albert M.K.. Instance-based learning algorithms1991;. · DOI · Paper page
  25. Barlow, 1989, Unsupervised learning, Neural Comput, 1, 295, 10.1162/neco.1989.1.3.295 · DOI · Paper page
  26. Kaelbling, 1996, Reinforcement learning: a survey, CoRR
  27. LeCun, 2015, Deep learning, Nature, 521, 436, 10.1038/nature14539 · DOI · Paper page
  28. Geoghegan, 2020, Orientalism and informatics: alterity from the chess-playing turk to Amazon’s mechanical turk, Ex-position, 45
  29. Goodfellow, 2014, Generative adversarial nets, vol. 27
  30. Johnson, 2016, Google’s multilingual neural machine translation system: enabling zero-shot translation, CoRR
  31. Ng, 2001, On discriminative vs. generative classifiers: a comparison of logistic regression and naive bayes, vol. 14
  32. Mirza, 2014, Conditional generative adversarial nets, CoRR
  33. Denton, 2015, Deep generative image models using a laplacian pyramid of adversarial networks, CoRR
  34. Radford A., Metz L., Chintala S.. Unsupervised representation learning with deep convolutional generative adversarial networks. arXiv preprint arXiv:1511064342015;.
  35. Chen, 2016, InfoGAN: interpretable representation learning by information maximizing generative adversarial nets, CoRR
  36. Vaswani, 2017, Attention is all you need, CoRR
  37. Méndez-Lucio, 2020, De novo generation of hit-like molecules from gene expression signatures using artificial intelligence, Nat Commun, 11, 1, 10.1038/s41467-019-13807-w · DOI · Paper page
  38. Lipton, 2015, A critical review of recurrent neural networks for sequence learning, arXiv preprint arXiv:150600019
  39. Martinez-Mayorga, 2020, The impact of chemoinformatics on drug discovery in the pharmaceutical industry, Expert Opin Drug Discov, 15, 293, 10.1080/17460441.2020.1696307 · DOI
  40. Weininger, 1988, Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules, J Chem Inf Comput Sci, 28, 31, 10.1021/ci00057a005 · DOI · Paper page
  41. Yin W., Fu Y., Sigal L., Xue X.. Semi-latent GAN: learning to generate and modify facial images from attributes. arXiv preprint arXiv:1704021662017.
  42. Wang, 2018, Beyond low-rank representations: orthogonal clustering basis reconstruction with optimized graph structure for multi-view spectral clustering, Neural Netw, 103, 1, 10.1016/j.neunet.2018.03.006 · DOI
  43. Liu, 2016, Coupled generative adversarial networks, Adv Neural Inf Process Syst, 29
  44. Xue, 2018, SegAN: adversarial network with multi-scale l1 loss for medical image segmentation, Neuroinformatics, 16, 383, 10.1007/s12021-018-9377-x · DOI · Paper page
  45. Bjerrum, 2018, Improving chemical autoencoder latent space and molecular de novo generation diversity with heteroencoders, Biomolecules, 8, 131, 10.3390/biom8040131 · DOI · Paper page
  46. Zhou S., Xiao T., Yang Y., Feng D., He Q., He W.. GeneGAN: learning object transfiguration and attribute subspace from unpaired data. arXiv preprint arXiv:1705049322017.
  47. Liu J., Li W., Pei H., Wang Y., Qu F., Qu Y., Chen Y.. Identity preserving generative adversarial network for cross-domain person re-identification. IEEE Access2019; 7:114021–114032. · DOI
  48. Vondrick, 2016, Generating videos with scene dynamics, Adv Neural Inf Process Syst, 29
  49. Zhou S.-F., Zhong W.-Z.. Drug design and discovery: principles and applications. 2017. · DOI
  50. Goh G.B., Siegel C., Vishnu A., Hodas N.O., Baker N.. Chemception: a deep neural network with minimal chemistry knowledge matches the performance of expert-developed QSAR/QSPR models. arXiv preprint arXiv:1706066892017b;.
  51. You, 2018, Graph convolutional policy network for goal-directed molecular graph generation, Adv Neural Inf Process Syst, 31
  52. Durant, 2002, Reoptimization of MDL keys for use in drug discovery, J Chem Inf Comput Sci, 42, 1273, 10.1021/ci010132r · DOI · Paper page
  53. Blanchard, 2021, Using GANs with adaptive training data to search for new molecules, J Cheminform, 13, 1, 10.1186/s13321-021-00494-3 · DOI · Paper page
  54. Lin, 2020, Relevant applications of generative adversarial networks in drug design and discovery: molecular de novo design, dimensionality reduction, and de novo peptide and protein design, Molecules, 25, 3250, 10.3390/molecules25143250 · DOI · Paper page
  55. Mouchlis, 2021, Advances in de novo drug design: from conventional to machine learning methods, Int J Mol Sci, 22, 1676, 10.3390/ijms22041676 · DOI · Paper page
  56. Sabban S., Markovsky M.. RamaNet: computational de novo helical protein backbone design using a long short-term memory generative adversarial neural network [version 1; peer review: 1 not]2020;. · doi:10.1101/671552
  57. Karimi, 2019, De novo protein design for novel folds using guided conditional wasserstein generative adversarial networks (gcWGAN), bioRxiv, 769919
  58. Anand, 2018, Generative modeling for protein structures, Adv Neural Inf Process Syst, 31
  59. Bian, 2019, Deep convolutional generative adversarial network (dcGAN) models for screening and design of small molecules targeting cannabinoid receptors, Mol Pharm, 16, 4451, 10.1021/acs.molpharmaceut.9b00500 · DOI
  60. Gupta A., Zou J.. Feedback GAN (FBGAN) for DNA: a novel feedback-loop architecture for optimizing protein functions. arXiv preprint arXiv:1804016942018;.
  61. Guimaraes G.L., Sanchez-Lengeling B., Outeiral C., Farias P.L.C., Aspuru-Guzik A.. Objective-reinforced generative adversarial networks (ORGAN) for sequence generation models. arXiv preprint arXiv:170510843
  62. Zhao, 2020, GANsDTA: predicting drug-target binding affinity using GANs, Front Genet, 1243, 10.3389/fgene.2019.01243 · DOI · Paper page
  63. Chen, 2018, The rise of deep learning in drug discovery, Drug Discov Today, 23, 1241, 10.1016/j.drudis.2018.01.039 · DOI · Paper page
  64. Zhavoronkov A.. Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. 2018. · DOI · Paper page
  65. Sanchez-Lengeling, 2018, Inverse molecular design using machine learning: generative models for matter engineering, Science, 361, 360, 10.1126/science.aat2663 · DOI · Paper page
  66. Kuhn, 2016, A real-world perspective on molecular design: miniperspective, J Med Chem, 59, 4087, 10.1021/acs.jmedchem.5b01875 · DOI
  67. Torchilin, 2000, Drug targeting, Eur J Pharm Sci, 11, S81, 10.1016/S0928-0987(00)00166-4 · DOI · Paper page
  68. Mukherjee S., Ghosh M., Basuchowdhuri P.. Deep graph convolutional network and LSTM based approach for predicting drug-target binding affinity. arXiv preprint arXiv:2201068722022;.
  69. Polykovskiy, 2018, Entangled conditional adversarial autoencoder for de novo drug discovery, Mol Pharm, 15, 4398, 10.1021/acs.molpharmaceut.8b00839 · DOI · Paper page
  70. Prykhodko, 2019, A de novo molecular generation method using latent vector based generative adversarial network, J Cheminform, 11, 1, 10.1186/s13321-019-0397-9 · DOI · Paper page
  71. Kadurin, 2017, The cornucopia of meaningful leads: applying deep adversarial autoencoders for new molecule development in oncology, Oncotarget, 8, 10883, 10.18632/oncotarget.14073 · DOI · Paper page
  72. Kadurin, 2017, DruGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico, Mol Pharm, 14, 3098, 10.1021/acs.molpharmaceut.7b00346 · DOI · Paper page
  73. Sanchez-Lengeling B., Outeiral C., Guimaraes G.L., Aspuru-Guzik A.. Optimizing distributions over molecular space. an objective-reinforced generative adversarial network for inverse-design chemistry (ORGANIC)2017b;. · DOI · Paper page
  74. Putin, 2018, Reinforced adversarial neural computer for de novo molecular design, J Chem Inf Model, 58, 1194, 10.1021/acs.jcim.7b00690 · DOI · Paper page
  75. Weininger, 1988, Smiles, a chemical language and information system. 1. Introduction to methodology and encoding rules, J Chem Inf Comput Sci, 28, 31, 10.1021/ci00057a005 · DOI · Paper page
  76. Heller, 2015, InChi, the IUPAC international chemical identifier, J Cheminform, 7, 1, 10.1186/s13321-015-0068-4 · DOI · Paper page
  77. Durant, 2002, Reoptimization of MDL keys for use in drug discovery, J Chem Inf Comput Sci, 42, 1273, 10.1021/ci010132r · DOI · Paper page
  78. Rogers, 2010, Extended-connectivity fingerprints, J Chem Inf Model, 50, 742, 10.1021/ci100050t · DOI · Paper page
  79. Glen, 2006, Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME, IDrugs, 9, 199
  80. Hert, 2004, Comparison of fingerprint-based methods for virtual screening using multiple bioactive reference structures, J Chem Inf Comput Sci, 44, 1177, 10.1021/ci034231b · DOI · Paper page
  81. Pérez-Nueno, 2009, APIF: a new interaction fingerprint based on atom pairs and its application to virtual screening, J Chem Inf Model, 49, 1245, 10.1021/ci900043r · DOI · Paper page
  82. Apweiler, 2004, UniProt: the universal protein knowledgebase, Nucleic Acids Res, 32, D115, 10.1093/nar/gkh131 · DOI · Paper page
  83. Berman, 2000, The protein data bank, Nucleic Acids Res, 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  84. Gaulton, 2017, The chEMBL database in 2017, Nucleic Acids Res, 45, D945, 10.1093/nar/gkw1074 · DOI · Paper page
  85. Papadatos, 2016, SurechEMBL: a large-scale, chemically annotated patent document database, Nucleic Acids Res, 44, D1220, 10.1093/nar/gkv1253 · DOI · Paper page
  86. Gilson, 2016, BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology, Nucleic Acids Res, 44, D1045, 10.1093/nar/gkv1072 · DOI · Paper page
  87. Huang, 2014, ASD v2. 0: updated content and novel features focusing on allosteric regulation, Nucleic Acids Res, 42, D510, 10.1093/nar/gkt1247 · DOI · Paper page
  88. O’Boyle, 2011, Open babel: an open chemical toolbox, J Cheminform, 3, 1
  89. Willighagen, 2017, The chemistry development kit (CDK) v2. 0: atom typing, depiction, molecular formulas, and substructure searching, J Cheminform, 9, 1
  90. Al-Rfou, 2016, Theano: a python framework for fast computation of mathematical expressions, arXiv e-prints, 1605
  91. Paszke, 2019, Pytorch: an imperative style, high-performance deep learning library, Adv Neural Inf Process Syst, 32
  92. Pedregosa, 2011, Scikit-learn: machine learning in python, J Mach Learn Res, 12, 2825
  93. Norgeot, 2019, A call for deep-learning healthcare, Nat Med, 25, 14, 10.1038/s41591-018-0320-3 · DOI · Paper page
  94. Yang, 2018, Clinical assistant diagnosis for electronic medical record based on convolutional neural network, Sci Rep, 8, 1
  95. Gkotsis, 2017, Characterisation of mental health conditions in social media using informed deep learning, Sci Rep, 7, 1
  96. Koscielny, 2010, Why most gene expression signatures of tumors have not been useful in the clinic, Sci Transl Med, 2, 10.1126/scitranslmed.3000313 · DOI · Paper page

Cited by

See all 59

Metadata

Authors
Tripathi, S., Augustin, A. I., Dunlop, A., Sukumaran, R., Dheer, S., Zavalny, A., Haslam, O., Austin, T., Donchez, J., Tripathi, P. K., & Kim, E.
Venue
Artificial Intelligence in the Life Sciences
Publisher
Elsevier BV
Published
2022-12
Volume
2
Pages
100045
ISSN
2667-3185 (ISSN-L)
OpenAlex
W4308043267
Cited by
59
References
40
FWCI
6.08
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recent advances and application of generative adversarial networks in drug discovery, development, and targeting. https://app.cochat.ai/papers/10.1016/j.ailsci.2022.100045
The paper
Tripathi, S., Augustin, A. I., Dunlop, A., Sukumaran, R., Dheer, S., Zavalny, A., Haslam, O., Austin, T., Donchez, J., Tripathi, P. K., & Kim, E. (2022). Recent advances and application of generative adversarial networks in drug discovery, development, and targeting. Artificial Intelligence in the Life Sciences. https://doi.org/10.1016/j.ailsci.2022.100045

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.